Kairos Tirzepatide Review: ODT Program, Costs & Care

Kairos Aesthetic and Longevity Medicine now lists a “Medical Weight Loss Program- Tirzepatide ODT, 90 days” in the Wellness menu of its public booking service. That is a specific medication listing, rather than a general promise of GLP-1 care. The public detail screen repeats the name but does not display a medication price, strength, pharmacy or fuller description before asking visitors to select a professional.¹

The listing is the reason to examine Kairos more closely, but it is not enough to judge the tablet's effectiveness or calculate a treatment total. Kairos's separate clinical pages explain its consultation, lab work and monitoring approach. The useful comparison is between that published care structure and the details still needed for this particular ODT program.^1,2

What Kairos offers, and what “90 days” leaves open

Kairos is a medical aesthetics and wellness practice in Las Colinas, Irving, Texas. Its weight-loss landing page describes in-clinic care or virtual care for Texas residents, a medical evaluation, a treatment plan based on symptoms and lab findings, shipped medications and ongoing support. These are the practice's published service descriptions; the ODT menu item does not separately specify its eligibility or shipment arrangements.^2,3

Kairos names Danielle Parker, NP-C, as leading its weight-loss program. Ask who will manage your ODT care and confirm that the clinician can treat you in your location. Treatment depends on an appropriate consultation under the practice's general terms.^2,4

A 90-day program label does not establish 90 tablets, daily dosing, a fixed quantity or an automatic renewal schedule. Request the actual preparation, directions and included supply before accepting a quote. Do not convert the duration into a monthly medication cost when the total itself is not public.¹

Consultation costs and cancellation terms

Kairos advertises a $250 comprehensive medical consultation. It includes reviewing medical history, considering metabolic markers and health goals, and determining eligibility for medication or other therapies. If testing is needed, the clinic describes an in-clinic draw or a CPL draw site; lab fees are excluded from the consultation charge. HSA payment is advertised.²

The ODT listing does not say that $250 buys the medication, covers the entire 90 days or is credited toward the program. Treat the consultation price and the unquoted medication program as separate items until Kairos supplies an itemized agreement. Our membership versus medication cost guide explains how to compare programs with separately billed care and medicine.

The February 2026 general terms require at least 24 hours' notice for cancellation or rescheduling and allow an unspecified fee for late cancellation or a missed appointment. Payment is due when services are rendered unless another arrangement applies. These appointment rules do not settle medication refunds, an early exit from the 90-day program, or what happens to payment if treatment is declined. Obtain those program-specific answers before paying.⁴

An ODT listing is not evidence of injectable results

The public listing uses “ODT” but supplies no explanation of its formulation, administration or absorption. It should not be presented as Zepbound in tablet form. Zepbound's prescribing information describes a tirzepatide injection for subcutaneous use; its dosing instructions and clinical results cannot simply be assigned to a different preparation.^1,5

Kairos's public menu also does not identify the ODT manufacturer or compounder. If the supplied preparation is compounded, FDA states that compounded drugs are not FDA-approved and do not receive its premarket review for safety, effectiveness and quality. FDA recommends discussing medical need with a prescriber and obtaining medication through a state-licensed pharmacy. This general guidance does not independently establish how Kairos's listed preparation is made or whether it is appropriate for an individual patient.⁶

For this program, ask the prescriber what supports the exact preparation and route being offered, not just whether tirzepatide injections have been studied. Our oral tirzepatide guide provides additional route context. Before committing to the program, get an itemized quote, the preparation and pharmacy details, and the cancellation terms in writing. The 90-day label alone does not answer those questions.